MIP?1ɑantagonist combined with bortezomib promotes osteoblasts in myeloma bone disease by inhibiting Erk1/2/Bax
CHEN Weiqiong
JIANG Fang
WANG Shanshan
HUANG Bo
QU Fujun
HUANG Lin
WANG Xiaotao
Machine-generated Keywords：
Publication Date：2021-06-25
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 1529-1533 )